Exosomal miR ‐26a‐5p From Urine‐Derived Stem Cells Mitigates Renal Fibrosis via Targeting NRAS
The FASEB Journal · 2026
DOI: 10.1096/fj.202504385rr ↗Kurz gefasst
Fachartikel in der Zeitschrift The FASEB Journal, 2026. Verfasst von Wenhong Jiang und 9 weiteren Autor:innen. Beteiligte Einrichtung: The Sixth Affiliated Hospital of Harbin Medical University, Harbin, China. Hauptthemen laut MEDLINE: MicroRNAs, Exosomes, Fibrosis, Stem Cells. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 50 Literaturangaben. Gefördert von: Key Research and development program of Heilongjiang Province.
Abstract (Originalsprache)
Renal fibrosis (RF) is a pivotal pathological feature in the progression of chronic kidney disease (CKD), yet its underlying mechanisms remain incompletely elucidated. Urine‐derived stem cells (USCs) exhibit significant potential in tissue repair due to their robust paracrine function. This study aimed to investigate whether miRNAs derived from USC‐derived exosomes (USC‐Exos) can inhibit RF and to elucidate the underlying molecular mechanisms. Based on preliminary research, miR‐26a‐5p was identified as a key regulatory molecule through miRNA high‐throughput sequencing of USC‐Exos. Integrative transcriptomic and single‐cell sequencing analyses revealed the expression characteristics and functional networks of its potential target gene, Nras , during the RF process. Subsequently, dual‐luciferase reporter gene assays confirmed that miR‐26a‐5p directly targets NRAS and negatively regulates its expression, thereby inhibiting fibroblast proliferation, migration, and the expression of fibrotic markers α‐SMA and Collagen I. Further mechanistic studies demonstrated that miR‐26a‐5p also suppresses the activation of the MAPK signaling pathway and mechanical signaling molecules (including PTK2 , SRC , RHOA , and ROCK1 ), reduces nuclear translocation of YAP protein, and inhibits F‐actin polymerization. Animal experiments confirmed that exosome‐delivered miR‐26a‐5p significantly attenuates renal histopathological damage, reduces collagen deposition, and downregulates the expression of various fibrosis‐related molecules. This study elucidates that miR‐26a‐5p from USC‐Exos alleviates RF progression by targeting NRAS, inhibiting the MAPK signaling pathway, and suppressing mechanical microenvironment activation, providing a potential novel strategy for clinical treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The Sixth Affiliated Hospital of Harbin Medical University, Harbin, China.
Förderung
- Key Research and development program of Heilongjiang Province
Zitieren
APA
Jiang, W., Guo, R., Wang, S., Li, X., Zhang, Z., Sun, Q., Piao, J., Zhao, Z., Yang, S., & Li, Z. (2026). Exosomal miR ‐26a‐5p From Urine‐Derived Stem Cells Mitigates Renal Fibrosis via Targeting NRAS. The FASEB Journal. https://doi.org/10.1096/fj.202504385rr
Vancouver
Jiang W, Guo R, Wang S, Li X, Zhang Z, Sun Q, et al. Exosomal miR ‐26a‐5p From Urine‐Derived Stem Cells Mitigates Renal Fibrosis via Targeting NRAS. The FASEB Journal. 2026. doi:10.1096/fj.202504385rr
BibTeX
@article{Jiang2026,
author = {Jiang, Wenhong and Guo, Rundong and Wang, Shuyao and Li, Xiangqi and Zhang, Zenan and Sun, Qijun and Piao, Jiayong and Zhao, Zheng and Yang, Shulong and Li, Zhaozhu},
title = {Exosomal miR ‐26a‐5p From Urine‐Derived Stem Cells Mitigates Renal Fibrosis via Targeting NRAS},
journal = {The FASEB Journal},
year = {2026},
doi = {10.1096/fj.202504385rr}
}
EUVIMED